WO2013079227A1 - Device and method for cooling a patient - Google Patents
Device and method for cooling a patient Download PDFInfo
- Publication number
- WO2013079227A1 WO2013079227A1 PCT/EP2012/065843 EP2012065843W WO2013079227A1 WO 2013079227 A1 WO2013079227 A1 WO 2013079227A1 EP 2012065843 W EP2012065843 W EP 2012065843W WO 2013079227 A1 WO2013079227 A1 WO 2013079227A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cannula
- gas
- patient
- mixture
- tube
- Prior art date
Links
- 238000001816 cooling Methods 0.000 title claims abstract description 91
- 238000000034 method Methods 0.000 title claims description 30
- 239000007789 gas Substances 0.000 claims abstract description 280
- 239000000203 mixture Substances 0.000 claims abstract description 55
- 230000000694 effects Effects 0.000 claims abstract description 26
- 210000004556 brain Anatomy 0.000 claims abstract description 23
- 210000001989 nasopharynx Anatomy 0.000 claims abstract description 20
- 230000002526 effect on cardiovascular system Effects 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 68
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 63
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims description 52
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 42
- 239000012530 fluid Substances 0.000 claims description 33
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 32
- 239000001272 nitrous oxide Substances 0.000 claims description 23
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 17
- 239000001301 oxygen Substances 0.000 claims description 17
- 229910052760 oxygen Inorganic materials 0.000 claims description 17
- 229910052786 argon Inorganic materials 0.000 claims description 16
- 239000001569 carbon dioxide Substances 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 15
- 210000003437 trachea Anatomy 0.000 claims description 15
- 239000004033 plastic Substances 0.000 claims description 12
- 229920003023 plastic Polymers 0.000 claims description 12
- 239000002184 metal Substances 0.000 claims description 11
- 229910052751 metal Inorganic materials 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 239000001307 helium Substances 0.000 claims description 7
- 229910052734 helium Inorganic materials 0.000 claims description 7
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 7
- 229910052743 krypton Inorganic materials 0.000 claims description 7
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 claims description 7
- 229910052754 neon Inorganic materials 0.000 claims description 7
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 claims description 7
- 229910052724 xenon Inorganic materials 0.000 claims description 7
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 4
- 229920000136 polysorbate Polymers 0.000 claims description 4
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 claims description 3
- 238000002627 tracheal intubation Methods 0.000 claims description 3
- 241001631457 Cannula Species 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- 238000011068 loading method Methods 0.000 claims description 2
- 235000002020 sage Nutrition 0.000 claims 1
- 239000002826 coolant Substances 0.000 abstract description 8
- 210000003928 nasal cavity Anatomy 0.000 abstract description 3
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 20
- 210000004072 lung Anatomy 0.000 description 13
- 238000003860 storage Methods 0.000 description 10
- 239000007792 gaseous phase Substances 0.000 description 9
- 210000003128 head Anatomy 0.000 description 9
- 238000009413 insulation Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 239000007791 liquid phase Substances 0.000 description 6
- 229920002379 silicone rubber Polymers 0.000 description 6
- 239000004945 silicone rubber Substances 0.000 description 6
- 238000009423 ventilation Methods 0.000 description 6
- 230000003788 cerebral perfusion Effects 0.000 description 5
- 230000001771 impaired effect Effects 0.000 description 5
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000004800 polyvinyl chloride Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 4
- 210000001331 nose Anatomy 0.000 description 4
- 210000003300 oropharynx Anatomy 0.000 description 4
- 229920000915 polyvinyl chloride Polymers 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000002631 hypothermal effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000010496 Heart Arrest Diseases 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000011796 hollow space material Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000000324 neuroprotective effect Effects 0.000 description 2
- -1 ni¬ trogen Chemical compound 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001103870 Adia Species 0.000 description 1
- 229910000975 Carbon steel Inorganic materials 0.000 description 1
- 241000123112 Cardium Species 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001274216 Naso Species 0.000 description 1
- 208000008457 Neurologic Manifestations Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001042 autoregulative effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- CUZMQPZYCDIHQL-VCTVXEGHSA-L calcium;(2s)-1-[(2s)-3-[(2r)-2-(cyclohexanecarbonylamino)propanoyl]sulfanyl-2-methylpropanoyl]pyrrolidine-2-carboxylate Chemical compound [Ca+2].N([C@H](C)C(=O)SC[C@@H](C)C(=O)N1[C@@H](CCC1)C([O-])=O)C(=O)C1CCCCC1.N([C@H](C)C(=O)SC[C@@H](C)C(=O)N1[C@@H](CCC1)C([O-])=O)C(=O)C1CCCCC1 CUZMQPZYCDIHQL-VCTVXEGHSA-L 0.000 description 1
- 239000010962 carbon steel Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000012809 cooling fluid Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000005496 eutectics Effects 0.000 description 1
- 239000004794 expanded polystyrene Substances 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/44—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0461—Nasoendotracheal tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0475—Tracheal tubes having openings in the tube
- A61M16/0477—Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids
- A61M16/0484—Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids at the distal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0486—Multi-lumen tracheal tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M19/00—Local anaesthesia; Hypothermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0002—Head or parts thereof
- A61F2007/0006—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0059—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
- A61F2007/0063—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling
- A61F2007/0064—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling of gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0095—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator
- A61F2007/0096—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator with a thermometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
- A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0488—Mouthpieces; Means for guiding, securing or introducing the tubes
- A61M16/0497—Tube stabilizer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0225—Carbon oxides, e.g. Carbon dioxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0283—Nitrous oxide (N2O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/03—Gases in liquid phase, e.g. cryogenic liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0618—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0625—Mouth
Definitions
- the present invention relates to methods and devices for provid ⁇ ing intracorporal and extracorporal cooling to a patient, in particular intranasal and intramouth cooling to protect the brain of a patient, as well as lung cooling to protect the myo ⁇ cardium and other organs of a patient such as kidney, liver and lungs according to the preambles of the independent claims.
- a non-invasive method of inducing therapeutic hypothermia is the use of blankets, vests or wraps that are equipped with a coolant liquid.
- the patient is placed in an ice bath to reduce the body temperature.
- This method requires the use of heavy and non transportable equipment and provides at the same time for a non-reliable, non-specific cooling effect that is greatly influenced by the patient's body mass.
- WO 2008/063179 Al proposes methods and devices for non-invasive cerebral and systemic cooling.
- a nebulized liquid is delivered as a mist or spray via the nasal cavities.
- the cooling effect rests on either direct heat transfer through the nasopharynx, evaporative heat loss and/or haematogenous cooling.
- the gases produced by evaporation of various forms of per fluorocarbon are used as a cooling media.
- WO 2008/094505 Al describes an apparatus and methods for cooling the brain using a cooled gas.
- This document discloses a pernasal intubation tube for insertion through the nostrils.
- the device further features an inflatable occluder.
- the occluder is adapted to occlude the nasopharynx such as to prevent the passage of liquid from the nasal cavities to the respiratory tract.
- Venous flow of blood to the brain is increased by applying a pressure device to the exterior of the nose and applying pressure to the angular vein.
- Cooling of the gas is made with a cooling coil, through which the gas passes or by adiabatic expansion of the gas upon exiting from a pressure container and prior to entering the patient's nasopharynx.
- a patient in the context of the present inven ⁇ tion is a mammal suffering or facing a considerable risk of impaired cerebral perfusion.
- the patient can be a human being in medical, or almost any type of animal in veterinary use.
- the de ⁇ vice is particularly useful for patients suffering from cardiovascular emergency.
- the device comprises a pressurised gas con ⁇ tainer for containing a gas or a mixture of gases.
- the gas con ⁇ tainer is preferably adapted to withstand the pressure of the gases stored therein.
- the gas container is adapted to hold a gas or mixture of gases whereby one gas is in essentially liquid form.
- the device further comprises at least one cannula sized and shaped for introduction into the patient's nasophar ⁇ ynx, in the patient's mouth or in the patient's trachea.
- the at least one cannula is from an essentially rod-like shape and can be functionally connected to the pressurised gas container ei ⁇ ther directly or by means of a flexible, e. g. bendable tube.
- the at least one cannula can be further sheathed in a soft mate ⁇ rial, such as silicone or PU for example.
- a soft mate ⁇ rial such as silicone or PU for example.
- the cannula is of an essentially semi-rigid material, such as PVC or PU or PP for example.
- the cannula is sized and shaped for introduction into the interior of blood vessels, in particular the vena cava. More preferably, the cannula is adapted as an intravascular ex ⁇ pandable balloon and provided with a cooling contact surface.
- the pressurised gas container and the at least one cannula are adapted to provide for adiabatic expansion of the gas or mixture of gases upon exit of the gas from the at least one cannula.
- the at least cannula features at least one interior lumen and at least two openings, one that functionally connects the cannula to the pressurized gas container and one that functions as exit point of the gas upon operation.
- the opening of the cannula closer to the pressurized gas container shall be termed the proximal end of the cannula, whereas the end of the cannula featuring the exit for the gas upon operation shall be referred to as the distal end of the cannula.
- the lumen forms a hollow space inside the cannula and upon operation, i. e. during gas release, is in fluid connection with the inside of the pressurized gas container.
- connection means are adapted to substantially prevent adiabatic expansion of the gas or mixture of gases upon passage from the container to the at least one cannula.
- a connection means according to the present invention can comprise individual components, such as a seal or sealant, a valve, a valve guard, a pressure regulator, a flow control, a switch, etc. for operating a valve, as well as stems and springs.
- connection means further com ⁇ prises an essentially flexible tube between the pressure bottle and the cannula.
- the flexible tube preferably has a length of from 50 mm to 1500 mm, more preferably 300 mm.
- the flexible tube can be of a material that withstands the high pressure of the gases, but still has pliability. Suitable flexible tubes can be manufactured of plastics.
- the flexible tube can have a supporting or strengthening wire mesh incorporated therein.
- the cannula is between 50 and 200 mm long, even more preferably between 60 and 180 mm long, and most preferably the cannula is around 100 mm long.
- the device can be fitted with a telescopic or exchange ⁇ able cannula that can be adapted to the patient's anatomy.
- the at least one cannula preferably may comprise at least one distal opening.
- the distal opening is adapted to enable an adia ⁇ batic expansion of the gas when exiting the cannula through the distal opening.
- the distal end of the cannula may be provided with an extension projecting there ⁇ from.
- This extension avoids closing of the distal opening if the distal end of the cannula abuts an area of the body of the pa ⁇ tient.
- this extension may be formed by at least one arch projecting from the distal end of the cannula.
- the arch or the arches may be formed on a cap which is attached to the distal end of the cannula.
- the extension may be formed by a cap having an outer surface with at least one hole formed therein.
- the cannula is made of a plastic material and a metal insert may be arranged at the distal end of the cannula for forming the distal opening.
- a metal insert allows for a more precise defini ⁇ tion of the distal opening. Furthermore, it also avoids a re ⁇ traction of the plastic material leading to a reduced diameter at lower temperatures.
- the cannula may be chosen such as to have a wall with a wall thickness which can withstand at least a cer ⁇ tain minimum pressure, typically which can withstand about the double of the maximum pressure within the gas container.
- bursting of the cannula e. g. in case of closed openings can be avoided.
- making the cannula with such a relatively high wall thickness might render the cannula thick and inflexible.
- the cannula at its proximal end may be provided with a pressure limiting member.
- Such pressure limiting member has a reduced diameter such that no adiabatic expansion occurs when the gas passes through this member. Nevertheless, the diameter is chosen such as to limit the maximum inner pressure within the cannula in case of burst of the cannula.
- the at least one cannula comprises at least one further opening beside the distal and proximal open ⁇ ings.
- the opening is adapted to enable adiabatic expansion of the gas or mixture of gases exiting the cannula.
- the at least one further openings are placed in rela ⁇ tive proximity to the distal opening and arranged evenly close to said end of the cannula.
- the cannula has more than two openings.
- the cannula has from two to thirty additional openings. In an even more pre ⁇ ferred embodiment, the cannula has from two to ten additional openings.
- the openings are constructed such as to provide for adiabatic expansion of the gas upon exiting the cannula.
- the cannula openings have a width of from about 50 to 300 ym to ensure that adiabatic expansion occurs upon exit of a gas.
- the device has a tube extend ⁇ ing into the pressurized bottle.
- the tube serves as in-flow of the gas during operation, e. g. when a fluid connection between a cannula and the pressurized bottle is established.
- the tube extends not deeper into the bottle, than half its po ⁇ tential filling height, i. e. the height of the bottle measured vertically from, for example, shoulders of the bottle up to its bottom. This can serve at preventing the liquefied gas to exit the bottle when the fluid connection between a cannula and the pressurized bottle is opened instead of the gaseous phase.
- a first small quantity of liquefied gas can exit the bottle before the gas exits the bot ⁇ tle. This is useful for providing a fast initial cool down. This can be accomplished by providing a cup around the inlet of the tube in the inside of the bottle. Upon shaking or upon filling the bottle through said tube, a small quantity of liquid gas, preferably liquid CO 2 or N20 remains in the cup. As soon as a fluid connection is established between the pressurized bottle and a cannula, i. e. the pressurized bottle is opened, this small quantity of liquefied gas exits the bottle and provides for a fast coolant effect in the patient's application area, e.g. the nasopharynx, the mouth or the lung.
- a fast coolant effect e.g. the nasopharynx, the mouth or the lung.
- the cannula in a first mode of application is inserted through the external nostrils into the patient's naso ⁇ pharynx and gas is released to exit the pressurised gas con ⁇ tainer through the connection means into the cannula.
- the gas adiabatically expands in the patient's nasopharynx upon exiting through the cannula openings. This results in an immediate cool ⁇ ing effect on the tissue of the nasopharynx and in ultimate proximity to the patient's brain. Cooling of the carotid pro ⁇ vides a further brain cooling effect.
- a cannula may be inserted into the mouth of the patient up to the oropharynx.
- a cooling is achieved at the application site, i. e. within the oropharynx and the mouth cavity.
- a cooling within the mouth is easier, simpler and may be added to a nasal cooling and the cooling effect can be increased.
- the application to the mouth may be easier than the application in the nose. Therefore, because of its simplicity, the application to the mouth can be easily performed by a non-trained medical personnel such as a family member or any lay person.
- an application of the cannula in the trachea of the patient may be used to cool the lungs, e. g. in order to use the lungs as a heat exchanger to cool the whole body, to protect the myocardium as well as other organs such as kidney, liver and lung after resuscitation. Cooling the lungs and thus protecting the myocardium and other organs may be done in combi ⁇ nation with the brain cooling through application of the inventive device in the mouth and/or in the nose but also can be used independently .
- the device may comprise fixation means for fixing the can ⁇ nula on an application site of the patient's body.
- the fixation means may also comprise sealing elements for seal- ingly attaching the cannula to an application site. Sealing members may e. g. be formed by a rubber band closing the mouth of the patient.
- the device can be easily stored at ambient temperature and there is no further need of coolant means or gases potentially hazard ⁇ ous for the patient or the environment, such as for example per fluorocarbon .
- the cannula is essentially straight or has a radius of curvature of up to 20 mm.
- the device comprises a tube for intubation which is arranged to receive the at least one cannula .
- the cannula comprises an internal, preferably essentially rigid inner tube and an external, preferably essentially soft, exter ⁇ nal tube, wherein said inner tube and external tube comprise at least one lumen.
- the inner tube comprises a first lumen and the external tube comprises a second lumen, whereby preferably the first and second lumens are in fluid connection by means of openings on the inner tube.
- the first and second lumens are further adapted to be brought into fluid connection with the nasopharynx by means of openings on the external tube.
- the second lumen comprises an outlet for removal of the gas, e.g. the carbon dioxide.
- Such arrangement allows adiabatic expansion of the pressurized gas from the first lumen to the second lumen, thereby providing a cooling effect while contact between the pressurized gas, e.g. CO 2 , and the patient is prevented or reduced.
- the pressurized gas e.g. CO 2
- the external tube comprising a second lumen is adapted to receive or comprise a solid or liquid, e.g. 3 ⁇ 40.
- the solid or liquid in the second lumen has a compa ⁇ rably high specific thermal capacity, i.e. a solid or liquid ab ⁇ sorbing more thermal energy without a substantial temperature increase than a majority of solids or liquids, preferably be ⁇ tween 100 to 5000 J/(kg-K), more preferably between 2000 to 4500 J/(kg-K), most preferably between 2060 to 4185 J/(kg-K) in normal conditions of temperature and pressure.
- the external tube encompassing the second lumen is substan ⁇ tially impermeable for liquids and gases during its intended use .
- Such liquid in the second lumen has the advantage that the gas undergoing an adiabatic expansion upon exiting the inner tube through the openings is cooling down the liquid while the latter is functioning as a storage medium for the generated cold.
- the cooling effect may advantageously be extended even after emptying the gas bottle.
- the pressurized gas within the first lumen before any adiabatic expansion has been influenced by the out ⁇ side temperature on the way between the pressurized gas con ⁇ tainer and the cannula thereby causing melting of such generated ice .
- Such mechanism of icing of the liquid and melting respectively breakage in particular at the distal end of the cannula is im ⁇ portant allowing a steady circulation of the gas.
- a varying gas (C0 2 ) flow may be observed by means of a flow meter.
- a eutectic liquid may be provided in the second lumen, e.g. a solution of sodium chloride, in order to decrease the icing temperature .
- the sheath of the external tube is com ⁇ prised by a flexible, in particular expandable, material.
- An ex ⁇ pandable sheath of the external tube has the advantage that upon expansion of the external tube when gas is supplied to the sec ⁇ ond lumen, the cannula can be brought in direct contact with the tissue of the patient, in particular with the tissue of the na ⁇ sopharynx and/or mouth of the patient.
- the device comprises a pressure valve arranged at an outlet of the second lumen and adapted to control the flow of the gas outside the second lumen. More preferably, the device is further adapted to control the gas flow between the first and second lumens .
- Such arrangement allows the adjustment of a gas flow between the first and second lumen which is higher than the gas flow through the pressure valve leading to a controllable expansion of the external tube.
- the cannula is received at least along the total length of the tube. More preferably, the end of the tube at the far side of the distal end of the cannula is outside the head of the patient. Preferably, such tube is a tracheal tube.
- a device com ⁇ prising a pressurized gas container and an inflatable bag, whereby the inflatable bag comprises a substantially closed sheath adapted to form an outer cooling contact surface upon inflation, and whereby the pressurized gas container and the in ⁇ flatable bag are adapted to provide a cooling effect in the bag upon release of gas, e.g. by adiabatic expansion of the gas or mixture of gases.
- WO 2006/000006 A2 proposes external cooling of a patient by means of an inflatable bag and a pressurized gas container stor ⁇ ing liquid air, wherein, however, the inflatable bag fully enve ⁇ lopes the patient resulting in a direct contact between vapor ⁇ ized liquid air and the patient.
- An arrangement with such an inflatable bag with an outer cooling surface advantageously results in an external cooling of the pa ⁇ tient while the chest of the patient is still available e.g. for resuscitation.
- the inflatable bag is adapted to form a tub upon in ⁇ flation to surround substantially the patient on the rear and lateral side.
- the inflatable bag is adapted to form a tub upon inflation to surround substantially the patient on the rear and lateral side leaving the head and arms outside.
- a form of the inflatable bag has the advantage that the arms are avail ⁇ able for intravenous liquid administration.
- the inflatable bag is formed as sleeveless vest to be wrapped around the patient.
- At least one tube may be arranged within the bag, in particular at the walls of the bag, and the at least one tube is inflatable upon release of gas from the pressurized gas container.
- the tube comprises at least one open ⁇ ing which is adapted to enable an adiabatic expansion of the gas when exiting the tube through the opening thereby providing a cooling effect.
- Cooling of the bag may be achieved upon release of the gas, e.g. CO 2 , into the bag and / or such tube within the bag comprising at least one opening adapted to enable adiabatic expansion of the gas.
- the bag may be inflated by pressurized gas from the pres ⁇ surized gas container and / or additionally inflated by a pres ⁇ surized gas from an additional gas source.
- a pressurized gas container and an inflat ⁇ able bag are functionally connected either directly or by means of a flexible tube.
- Such inflatable bag has the advantage that external cooling of the patient's body can be achieved. It can be easily used in combination with a cooling cannula as shown above thereby using a pressurized fluid container for achieving multiple cooling ef ⁇ fects. However, such a bag cooled by a pressurized gas is also advantageous without such a cannula.
- the gas container is adapted to hold a gas or mixture of gases chosen from the group consist ⁇ ing of oxygen, nitrogen, carbon dioxide, nitrous oxide, helium, neon, argon, krypton and xenon.
- the mixture of gases is oxygen, carbon dioxide, nitrous oxide and argon.
- the carbon dioxide or nitrous oxide is pres ⁇ surized in the bottle such as to liquefy.
- the bottle thus con ⁇ tains a liquid phase of carbon dioxide or nitrous oxide and a gaseous phase of oxygen, argon, nitrous oxide and carbon diox ⁇ ide.
- the pressure in the bottle ensures the gases are propelled out of the bottle upon operation, i. e. establishing a fluid connection between the cannula and the pressurized bottle through opening the connection means.
- the gases are preferably medical grade.
- the pressurized gas bottle is chosen in size, such as to hold preferably volume of from 0.5 to 5 litres, more preferably 1 1. It has been found, that 500 g of liquefied CO 2 is enough to pro ⁇ vide 267 litres of CO 2 after expansion, for instance.
- a cooling effect because of the change of the liquid to a gase ⁇ ous state may also occur at the pressurized gas bottle attached to the cannula.
- a device is provided com ⁇ prising a pressurized gas container and at least one cannula, wherein the pressurized gas container and / or parts of the can ⁇ nula are substantially encompassed by a means for the retrieval of cold.
- the means for the retrieval of cold is provided by a serpentine coiled around the pressurized gas bottle and / or the cannula.
- the serpentine is a flexible tube.
- the fluid within the serpentine may be a gas such as O 2 supplied at low pressure.
- the means for the retrieval of cold may be pro ⁇ vided by a hollow jacket.
- the jacket has entry and exit ports, one of which is functionally connected to the can ⁇ nula, in particular by a flexible tube and the other to a source of gas such as O 2 .
- the pressurized gas bottle and / or the cannula is encompassed by a thermal insulation layer.
- the serpentine is encompassed by a thermal insulation layer .
- the arrangement of a serpentine supports the retrieval of cold.
- the serpentine is functionally connected to a cannula as shown hereinabove for providing additional cold to a patient, thereby used in combination.
- a cannula as shown hereinabove for providing additional cold to a patient, thereby used in combination.
- such means for retrieval of cold is also advantageous without the cannula as shown hereinabove providing cold to a separate cannula.
- the fluid passing through the serpentine is cooled and may be used for additionally cooling the patient. This can e.g. be achieved by administering the cooled fluid (which may be 0 2 ) to the patient. Alternatively, the cooled fluid may also be pro ⁇ vided to cool a bag as described above.
- the additional cold administered by the serpentine may be provided by a connection means between the serpentine and the inside of the cannula.
- a connection means between the serpentine and the inside of the cannula Such arrangement has the advantage that the pressurized gas can be cooled before the adiabatic ex ⁇ pansion at the distal end of the cannula.
- a separate cannula is arranged at the end of the serpentine for usage at an application site.
- such cannula of the serpentine may be arranged in parallel to the cannula which is connected to the pressurized gas container.
- the arrangement of thermal insulation layer encom ⁇ passing the serpentine reduces the introduction of ambient heat to the surface of the serpentine or hollow jacket.
- the thermal insulation layer is composed of expanded or extruded polystyrene .
- the pressurized gas bottle may be formed in such a way that it can be positioned at an external application site of the patient.
- the external application site may be the neck of the patient. This results in an additional external cooling.
- the pressurized gas bottle generating cold may be encompassed by a casing sized and shaped for the usage as neck pillow. More preferably, the casing of the bottle is essentially of a flexible and heat conductive material, such as metal or composite to allow an efficient transfer of the cooling energy to the patient.
- the device comprises two can ⁇ nulas instead of one.
- the cannulas are then adapted for inser ⁇ tion into one nasal opening each.
- the device is also equipped with a temperature sensor.
- the temperature sensor is preferably close or at the distal end of the cannula.
- Further preferred embodiments encompass an electrical controller or regulator for regulating and adjusting the volume per minute of gas exiting the pressurized bottle, the desired temperature and/or the length and duration of gas exit. It has been found to be further advantageous to provide a feedback mechanism and auto regulatory function in feedback with a sensor at the distal end of the cannula. By such means, a desired temperature in the na ⁇ sopharynx or oropharynx can be compared with the actual tempera- ture achieved. Safety mechanisms can thus further be included for preventing the cooling to go below a certain threshold.
- Said electrical controller or regulator can be equipped with a power supply.
- regular power supplies such as lithium batteries have proven to be efficient.
- a device comprises a pres ⁇ surized gas container with at least one cannula for application of a gas or mixture of gas to an application site and an atom ⁇ izer, wherein the atomizer is arranged at the cannula.
- the atomizer is adapted to atomize a fluid contain ⁇ ing an active pharmaceutical ingredient such as an antibiotic. More preferably, the atomizer is connected by a tube to a gas source, preferably a source of CO 2 and /or O 2 , for atomizing the fluid. A further tube may be arranged at the atomizer for pro ⁇ viding the fluid from a fluid source. Even more preferably, the atomizer is arranged at the distal end of the cannula.
- Such arrangement of an atomizer allows the transport and appli ⁇ cation of an active pharmaceutical ingredient to a preferred body part of the patient, e.g. the lungs in case of pneumonia or to prevent pneumonia. This is advantageous since pneumonia is the most frequent complication reported after therapeutic cool ⁇ ing of a patient as provided by the present invention. Thus, it is the role of the atomizer to spread an antibiotic or similar bactericid for the prevention of an infection.
- the set is particularly useful for installation into a first-aid facility such as an emergency car or a fixed or movable first-aid station.
- the set comprises a device as previously described with a pressurized gas container for containing a gas or a mixture of gases, at least one cannula for introduction into a patient's opening, e. g. the nasopharynx or oropharynx and adapted to provide for adiabatic expansion of the gas or mixture of gases upon exit from the cannula.
- the set further comprises a gas source for loading said device with a gas or mixture of gases.
- the gas source can be a source of a gas or mixture of gases chosen from the group of: oxygen, carbon di ⁇ oxide, helium, neon, argon, nitrous oxide, krypton and xenon.
- the gas source is a source of oxygen, carbon dioxide, nitrous oxide and argon.
- the gas or mixture of gases does not contain any per fluorocarbon .
- the pressurized gas container is adapted to receive a mixture of liquid CO 2 or liquid 2O and liquid O2 or liquid N 2 .
- the pressurized gas container is adapted to receive a mixture of liquid CO 2 or liquid 2 O and liquid O 2 or 2 in a non-closed state of the pressurized gas container.
- a stabilizing agent is added to the mixture of liq ⁇ uid CO 2 or liquid 2 O and liquid O 2 or 2 into the pressurized gas container.
- the stabilizing agent may be an inert material, pref ⁇ erably in powder form.
- the mixture of liquids in the pressurized gas container in a non-closed state may leak out during handling.
- a stabilizing agent in the mixture of liquids may work as a sponge, thereby reducing the risk of leakage and facilitating the handling of the pressurized gas container.
- the bottle Since the bottle is occupied by an inert material working as a sponge, the liquefied gas is prevented to exit the bottle in ⁇ stead of the gaseous phase when the fluid connection between a cannula and the pressurized bottle is opened.
- the storage of a gas or mixture of gas in liquid form such as liquid O 2 or liquid 2 may be guaranteed by maintaining a suffi ⁇ cient cooling and / or a sufficient pressure in a storage means. Since storage of the mixture in a non-closed state of the pres ⁇ surized gas container only allows storage of a gas at low pres ⁇ sure, low temperature has to be established in the pressurized gas container.
- the pressurized gas container com ⁇ prises a thermal isolation layer adapted to allow the storage of a mixture of liquid CO2 or liquid 2O and liquid O2 or liquid 2 in a non-closed state of the pressurized gas container at a tem ⁇ perature of -196°C.
- Such thermal isolation layer of the pressur ⁇ ized gas container may be comprised by expanded polystyrene.
- a sufficiently low temperature , gas pressurized at up to 1000 bar may be achieved in the ullage of the pressurized gas con ⁇ tainer by limiting the passage of the gas flow outside the pres ⁇ surized gas container by the closing means.
- the pressurized gas container is adapted for suffi ⁇ cient isolation against upper outside temperatures of about 70 to 80°C.
- containers of other sources of gas such as 2O are used in ambulances which may ad ⁇ vantageously stabilize the storage temperature of the pressur ⁇ ized gas container.
- At least one of the gas or mixture of gases in the gas source is stored as a liquid.
- the gas needs to be under sufficient pressure to be stored as a liq ⁇ uid in the pressurized bottle.
- Means for converting gases into the liquid state are known.
- pressurization is the preferred way of storing the gases in the pressurized gas container.
- CO2 or N20 is pressurized at around 60 bar, such as to be present in liquid state in the gas source.
- One further aspect of the present invention is a method for pro ⁇ viding intracorporal cooling of a patient, in particular for providing intranasal or intra mouth cooling to the brain of a patient. This method is particularly useful for a patient suf ⁇ fering from cardiovascular emergency.
- a device for cooling the brain as previously described is provided. At least one cannula of said device is inserted through the external nostrils into the patient's nasopharynx.
- a gas or a mixture of gases is pro ⁇ vided to exit the at least one cannula by opening a connection means between cannula and pressurized gas container. The gas is cooled by means of adiabatic expansion upon exiting the cannula and entering the nasopharynx of the patient in one mode of op ⁇ eration .
- the cannula is inserted into the mouth of the patient. Upon release of the gas through the cannula and by means of adiabatic expansion the gas is cooled and thereby cools the patient's brain.
- a cannula is inserted into the trachea of a patient and produces a cooling effect on the patient's lung upon exiting the cannula.
- a device which comprises a source of fluid adapted to generate cool upon application from the source.
- the device is adapted to be applied to a patient's mouth or to the patient's trachea.
- a further aspect of the invention is directed to a method for providing intracorporal cooling to a patient wherein a fluid is applied to an application site of the pa ⁇ tient.
- the fluid is adapted to generate cold upon application.
- the application site is selected from the mouth or the trachea of the patient.
- the method is performed with a mix ⁇ ture of gases selected from the group consisting of: oxygen, ni ⁇ trogen, carbon dioxide, helium, neon, argon, nitrous oxide, krypton and xenon.
- a mix ⁇ ture of gases selected from the group consisting of: oxygen, ni ⁇ trogen, carbon dioxide, helium, neon, argon, nitrous oxide, krypton and xenon.
- the method is performed with oxy ⁇ gen and at least one further gas of said group.
- At least one noble gas is used in addition to oxygen.
- the liquid phase consists of liquid CO2 , or liquid N 2 0 and the gaseous phase of gaseous O2 , CO2 ni ⁇ trous oxide, and Ar .
- the mixture in the gaseous phase exits first, whereas liquid CO2 or nitrous oxide of the liquid phase evaporates and resupplies the CO2 or nitrous oxide content of the gaseous phase.
- CO2 or nitrous ox ⁇ ide serves as propellant for the gas as well as coolant, by means of adiabatic expansion upon exiting the device.
- a further aspect of the invention is directed to a method.
- the method comprises coupling of a pressurized gas container with an inflatable bag. Pressurized gas from the pressurized gas con ⁇ tainer is supplied to the inflatable bag by opening a connection means for providing a cooling effect to a patient.
- the pressurized gas is cooled by a cooling means to provide external cooling to a patient. More preferably, the cooling effect is achieved by adiabatic expansion of the gas.
- a further aspect of the invention is directed to a method for applying an active pharmaceutical to an application site.
- the method comprises the steps of coupling a pressurized gas con ⁇ tainer and at least one cannula (8) for application of a gas or mixture of gas to an application site.
- an at ⁇ omizer is connected to the cannula and operated for applying the active pharmaceutical ingredient to the application site.
- a further aspect of the invention is directed to a method for providing intracorporal cooling to a patient.
- a pressurized gas container and at least one cannula are coupled.
- the pressurized gas container and / or parts of the cannula are encompassed by a means for the retrieval of cold.
- Figure 1 shows a schematic drawing of a pressurized bottle according to the present invention
- Figure 2 shows a schematic drawing of a cross-section of the head of a patient with an inserted cannula according to the present invention shows a schematic drawing of the distal end of a cannula according to the present invention shows a schematic representation of a set with a gas source and a device according to the present inven ⁇ tion.
- FIG. 1 shows a schematic drawing of a pneumatic switching circuit for a device according to the present inven ⁇ tion show fixation means for fixing a cannula to a patient' s nose show fixation means for fixing a cannula to a patient' s mouth show a first embodiment of an extension at the dis ⁇ tal end of a cannula
- Figures 9a show a second embodiment of an extension applied to and 9b: the distal end of the cannula
- Figures 10a show a schematic cross sectional and top view of a and 10b: distal end of the cannula
- Figure 11 shows a schematic cross sectional view of a proximal end of the cannula
- Figure 12 shows a schematic view of a device for tracheal
- Figure 13 shows a schematic view of a pressurized bottle
- Figure 14 shows a schematic view of a pressurized bottle
- Figure 15 shows a schematic representation of an inflatable bag connected with a pressurized gas container
- Figure 16 shows a cross-sectional view through the inflatable bag connected with the pressurized gas container
- Figure 17 shows a schematic drawing of a cross-section of the head of a patient with an inserted tracheal tube surrounding the cannula for intramouth cooling and ventilation
- Figure 18 shows a schematic drawing of an inserted tracheal tube with the cannula applied within the lumen of a tracheal tube
- Figure 19 shows a schematic drawing of the distal end of a
- cannula according to the present invention with liquid in a second lumen
- Fig. 1 shows a pressurized gas bottle 1 made of metal or compos ⁇ ite material, containing a pressurized gas in a liquid phase 2, carbon dioxide, nitrous oxide and gaseous phase 3, carbon diox ⁇ ide, oxygen, nitrogen, nitrous oxide and argon.
- a metallic or PVC connection tube 4 extends into the interior hollow space of the pressurized bottle 1.
- the pressurized bottle 1 is required to be able to resist pressures of at least 100 bar.
- a gate valve 5 is operably placed between a duct 30 and the pressurized bottle 1 and is used to trigger the discharge of the gas into the cannula 8 (not shown in Fig.l) through the duct 30 and a flexible wire-mesh reinforced tube 31.
- the flexible tube 31 has a length of 30cm.
- a check valve 6 serves for one-way filling the bottle with the gas or mixture of gases or liquefied gases (see also Fig. 5) . In case of excess pressure inside the bottle, such as resulting from improper storage or excess ambi ⁇ ent heat, safety valve 7 decompresses the gases and prevents ex ⁇ plosion.
- the pressurized bottle 1 is adapted to hold an equiva ⁇ lent volume of 1 litre of the pressurized mixture of gases and has dimensions of 25 cm height and 10 cm width.
- Gate valve 5, duct 30, check valve 6 and safety valve 7 form a connection means 32 between the flexible tube 31 and the pressurized bottle 1 that reduces to a negligible degree adiabatic expansion of the gas upon opening the gate valve 5 and conducts the gas into the cannula 8 (not shown in Fig.l) .
- the distal end 9 of the duct 30 is barbed, such as to enable stably fitting the flexible tube 31 onto the duct 30.
- the mixture of gases consists of oxygen, nitrogen, carbon dioxide, nitrous oxide, and argon.
- a liquid phase 2 consists mainly of liquid carbon dioxide or nitrous ox ⁇ ide.
- a gaseous phase 3 consists of gaseous carbon dioxide or gaseous nitrous oxide, gaseous oxygen, gaseous nitrogen and gaseous argon.
- the gases are medical grade gases. Medical grade gases and pressure bottles 1 can be supplied by Linde Group, Mu ⁇ nich (DE) for instance.
- a tube 4 extends from the connection means 32 into the inside of the pressurized bottle 1.
- the tube 4 has a slightly pointed tip and is covered by a cap 10, which semi-circularly encases the tip, such as to leave a pocket be ⁇ tween the tip and the cap 19.
- the cap 10 thus forms a cup around the tip of the tube 4.
- this cap 10 fills with a small quantity liquid CO 2 or nitrous oxide 33, thus providing for a first shot of liquid CO 2 or nitrous ox ⁇ ide to the patient upon opening of the gate valve 5.
- This shot provides for a first rapid cooling effect, after which the gase ⁇ ous phase 3 is released from the bottle.
- the cup typically may have a volume of about 0.5 ml .
- the tube 4 is constructed, such as to prevent to dip into the liquid phase 2.
- the filling level b of the pressurized bottle is half or less than half the bottle height a, thereby accidentally releasing liquid CO 2 or nitrous oxide is prevented regardless of the bottle position.
- the cannula 8 with a proximal end 8'' and a distal end 8' is shown inserted in a human patient's 12 nasopharynx 13 in Fig. 2.
- the cannula 8 is inserted with distal end 8' first through the external nostrils 11 of the patient 12 into the nasopharynx 13.
- the pressurized gas exits the cannula at its distal end 8' and by means of adiabatic expansion cools the surrounding region. This creates a cool atmosphere in the nasopharynx 13 and pro ⁇ vides a coolant effect through heat transfer cools the cranium postero-inferior bone 14, thereby causing a coolant effect on the brain 15.
- the cannula 8 in the present example is of a semi-rigid mate ⁇ rial, either metal or plastic (PVC) for example, and coated with silicone rubber as an external tube.
- the silicone rubber can be a replaceable single use coating facilitating lubrification and insertion through the nostrils.
- a temperature of around .5 °C of the CO 2 is achieved upon exit at the distal end 8' of the cannula 8.
- the cannula is shown in further detail in Fig. 3.
- the distal end 8' of the cannula consists of a silicone rubber external tube 18 around a semi-rigid plastic (PVC) internal tube 17.
- a lumen 16 has a fluid connection with the outside by means of openings 21 in the semi-rigid plastic tube 17 and holes 20 in the external silicone rubber tube 18.
- the construction can pro ⁇ vide for a further interior lumen between the semi-rigid plastic tube 17 and the external silicone rubber tube 18, thereby caus ⁇ ing the gas to undergo a main adiabatic expansion in said fur ⁇ ther interior lumen upon exiting the semi-rigid plastic tube 17 and a second minor adiabatic expansion upon exiting the external silicone rubber tube 18. This enables the cooling effect to be more evenly distributed.
- FIG. 4 A set according to the invention is shown in Fig. 4.
- the device 22 for cooling intra nasally the brain consisting essentially of a cannula 24, a connecting means 25 and a pressurized gas container 26 can be functionally connected to a gas storage means 23 containing a mixture of gases, preferably a mixture of carbon dioxide or nitrous oxide and oxygen. This results in a set 27 for intranasally cooling the brain or the mouth.
- FIGs 6a and 6b schematically show a cannula 8 applied to the patient 12 through the nostrils 11.
- the cannula 8 is fixed at this site by means of a strap 40.
- the strap 40 e. g. may com ⁇ prise a Velcro arrangement for quick application and release.
- the cannula 8 may be attached to the strap 40 by means of glue 41.
- Figures 7a and 7b show a fixation device for applying a cannula 8 to the mouth of a patient.
- the cannula 8 is held in place at the mouth of a patient by means of a strap 50 which can be fixed around the head of the patient by means of e. g. a Velcro fixa ⁇ tion.
- the strap 50 is provided with a sealing mask 52 made of rubber which can be sealingly applied to the patient's mouth.
- the cannula may be attached to the sealing member 52 by means of glue 51.
- an extension is provided.
- the extension is made in the form of a cap 34 comprising one arch 35 arranged at the distal end 8' of the cannula 8 on oppo ⁇ site sites of the distal opening 19.
- the arch 35 avoids closing of the distal orifice 19 by contact of the distal end 8' of the cannula 8 with parts of the patient's body.
- Figure 8b shows a top view to the distal end of the cannula.
- the arch 35 bridges the distal opening 19 of the cannula without closing it.
- Figures 9a and 9b show an alternative embodiment with three arches which are arranged circumferentially at 120° whereas the embodiment of Fig. 8b shows an arrangement at 180° with one sin ⁇ gle arch 25.
- a cap 34 which can be made separately from the cannula and which may be attached to the distal end of the cannula 8.
- a cap 34 may be made of a plastic material by injection moulding or also may be formed as a metal piece.
- Figures 10a and 10b show an alternative embodiment of a distal end of a cannula.
- the cannula 8 is made of a plastic material and at the distal end of the cannula 8 there is arranged a metal insert 36.
- the metal insert 36 has a reduced cross section at its distal end thereby forming the distal orifice 19.
- the metal insert 36 has a contoured outer circumferential surface allowing a friction and/or form-fit connection with the inner surface of the cannula 8. It is furthermore possible to also apply arches as shown in Fig. 8a or Fig. 9a in combination with the insert shown in Fig. 10a.
- the arches may be integrally formed with the insert 36 or as a separate piece.
- Figure 11 schematically shows the cross section of a cannula 8 at its proximal end.
- the proximal end 8'' of the cannula 8 is provided with an insert 37 having a reduced diameter d.
- the di ⁇ ameter d is chosen such as to avoid adiabatic expansion when the fluid passes through the insert 37.
- the diameter d is chosen such as to limit the pressure within the lumen of the cannula 8.
- Figure 12 shows an alternative application of the cannula 8 ac ⁇ cording to the invention.
- the cannula 8 is applied within the lumen of an endotracheal tube 60 within the trachea T.
- the en ⁇ dotracheal tube is a standard tube which can be applied to the trachea e. g. through a laterally cut incision which may be pro ⁇ vided by first aid personnel.
- the endotracheal tube is provided with a cuff 61.
- the cannula 8 may be inserted through the tube to the application site shortly before the bifurcation of the trachea for cooling the lungs of a patient.
- gas G exits the cannula 8 because of adiabatic expansion the area close to the distal end 8' of the cannula is cooled. It is of course also possible to use specifically suitable tubes for application of the cannula 8 in the trachea. Also instead of a gas cooling upon adiabatic expansion liquids carrying a cooling effect upon evaporation may be used.
- FIG. 12 only shows application at the trachea, it is of course understood that such a cooling may be used in combination with cooling in the nasopharynx or in the mouth as it has been shown hereinabove.
- Fig.13 shows the pressurized bottle 1 with a serpentine 65.
- the serpentine 65 is formed by a flexible tube which is coiled around the pressurized gas bottle 1. Such flexible tube has a diameter of 6 mm and is composed of a plastic material.
- the fluid passing through the serpentine 65 is O 2 supplied from a source of O 2 , e.g. a pressurized O 2 bottle.
- An inlet side 63 of the serpentine 65 connects the serpentine 65 to a source of O 2 (not shown in Fig.13) whereas an outlet side 64 of the serpen ⁇ tine 65 is connected to a separate cannula 8.
- Fig.13 further shows a thermal insulation layer 70 encompassing the serpentine 65 and the neck of the pressurized bottle 1.
- the thermal insulation layer 70 is composed of expanded or extruded polystyrene.
- Fig.14 shows a hollow jacket 66 around the pressurized bottle 1.
- the jacket 66 and the neck of the pressurized bottle 1 is encom ⁇ passed by the thermal insulation layer 70.
- the hollow jacket 66 has an entry port 67 and an exit port 68 for supplying a cooling fluid in a similar manner as shown in context with Fig.13.
- the entry port 67 is connected to a source of O 2 (not shown in Fig.14) .
- the exit port 68 is connected to the cannula (not shown in Fig.14) to provide additional cooling to a patient.
- Fig.15 shows a pressurized gas container 26 which is connected by a connecting means 25 and a flexible tube 24 with the cannula 8.
- the flexible tube 24 further comprises a branch 28 for con ⁇ necting the pressurized gas container 26 with a tube 77 of an inflatable bag 75 as well.
- the tube 77 is coiled along the pa ⁇ tient-sided wall of the inflatable bag 75. Pressurized gas en ⁇ tering the tube 77 inflates the latter. Upon inflation the pressurized gas expands adiabatically through the openings 78 of the tube 77 thereby cooling the patient P externally.
- the inflatable bag 75 and the tube 77 can be made of rubber while the rubber may be reinforced by tissue.
- the inflatable bag 75 forms a tub surrounding the patient on the rear and lateral side. The head and both arms are left outside of the bag 75 and the arms remain available for intravenous liquid administration.
- Fig.16 shows a cross-sectional view through the inflatable bag 75 whereby the tube 77 of the inflatable bag 75 is connected with the pressurized gas container 26 by a flexible tube 24 and a connecting member 25.
- the head and both arms of the patient P are left outside of the bag 75.
- the tube 77 of the inflatable bag 75 is arranged along the patient-sided wall of the inflat ⁇ able bag 75 for efficient external cooling of the patient P.
- Fig.17 shows a schematic drawing of a cross-section of the head of a patient.
- a tracheal tube 60 is inserted through the mouth of the patient surrounding the cannula 8 as shown in Fig.12. The far side of the tube at the far side of the distal end of the cannula is outside the head of the patient.
- the tracheal tube is provided with a cuff 61.
- the cannula 8 is inserted through the tube to the application site shortly before the bifurcation of the trachea for cooling the lungs of the patient.
- the tracheal tube 60 comprises a branch 92 with an inlet for sealingly arranging the cannula 8 and an inlet for sealingly arranging a ventilation tube 91.
- the arrangement of the ventilation tube 91 at the tracheal tube 60 allows access to the lungs of the pa ⁇ tient for artificial ventilation while cold is administered by the cannula 8.
- the tracheal tube 60 is essentially of a flexible material such as polyvinylchloride (PVC) and / or polypropylene (PP) .
- Fig.18 shows a schematic drawing of a tracheal tube 60 inserted into the trachea of a patient as shown in Fig. 12 or 17 with the cannula 8 applied within the lumen of a tracheal tube 60.
- the distal end 8' of the cannula 8 consists of an external tube 18 around the internal tube 17 which has already been shown in Fig.3.
- the lumen 16 has a fluid connection with a further inte ⁇ rior lumen 62 between the internal tube 17 and external tube 18 by means of openings 21.
- the external tube 18 is of a soft mate ⁇ rial such as silicone.
- the gas undergoes an adiabatic expansion upon exiting the internal tube 17 through the openings 21 into the further interior lumen 62.
- the further interior lumen 62 comprises an outlet 59 for removal of the gas, e.g. the CO 2 , thereby preventing or minimizing contact between the gas and the patient .
- Fig.19 shows a schematic drawing of the distal end 8' of the cannula 8 as already shown in Fig.3 and Fig.18 comprising an ex ⁇ ternal tube 18 around the internal tube 17.
- the first lumen 16 has a fluid connection with the second lumen 62 between the internal tube 17 and the external tube 18 by the means of openings 21.
- the second lumen 62 is adapted to receive a liquid L such as water.
- the liquid may be already present in the second lumen 62 before the operation of the device.
- the gas undergoing an adia- batic expansion upon exiting the internal tube 17 through the openings 21 is cooling down and freezing the water, wherein the latter is functioning as a storage medium for the cold.
- the openings 21 may be adapted to be permeable substantially only for the gas and not for the liquid.
- a pressure valve 57 is ar ⁇ ranged at an outlet for the gas which controls the flow of the gas outside the second lumen. An adjustment of a gas flow be ⁇ tween the first and second lumens which is higher than the gas flow through the pressure valve 57 leads to a controllable ex ⁇ pansion of the external tube 18.
- Fig.19 shows an expanded exter ⁇ nal tube 18 which is brought in direct contact with the tissue of the mouth of the patient P.
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112014013139A BR112014013139A2 (en) | 2011-12-02 | 2012-08-14 | device and method for cooling a patient |
CA2855859A CA2855859A1 (en) | 2011-12-02 | 2012-08-14 | Device and method for cooling a patient |
US14/360,823 US9622908B2 (en) | 2011-12-02 | 2012-08-14 | Device and method for cooling a patient |
CN201280059586.8A CN103987346B (en) | 2011-12-02 | 2012-08-14 | Apparatus and method for cooling down patient |
EP12748677.7A EP2785293A1 (en) | 2011-12-02 | 2012-08-14 | Device and method for cooling a patient |
AU2012344233A AU2012344233A1 (en) | 2011-12-02 | 2012-08-14 | Device and method for cooling a patient |
IL232722A IL232722A0 (en) | 2011-12-02 | 2014-05-20 | Device and method for cooling a patient |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11191745.6A EP2599465B1 (en) | 2011-12-02 | 2011-12-02 | Device for intracorporally cooling a patient |
EP11191745.6 | 2011-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013079227A1 true WO2013079227A1 (en) | 2013-06-06 |
Family
ID=46717829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2012/065843 WO2013079227A1 (en) | 2011-12-02 | 2012-08-14 | Device and method for cooling a patient |
Country Status (8)
Country | Link |
---|---|
US (1) | US9622908B2 (en) |
EP (2) | EP2599465B1 (en) |
CN (1) | CN103987346B (en) |
AU (1) | AU2012344233A1 (en) |
BR (1) | BR112014013139A2 (en) |
CA (1) | CA2855859A1 (en) |
IL (1) | IL232722A0 (en) |
WO (1) | WO2013079227A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018046128A1 (en) | 2016-09-09 | 2018-03-15 | Fabian Temme | Transportable device, system and method for providing a cooled, oxygen-containing gas flow |
WO2019072423A1 (en) * | 2017-10-11 | 2019-04-18 | Quickcool Ab | System for hypothermia treatment of a patient |
US11737912B2 (en) | 2018-01-08 | 2023-08-29 | Vivonics, Inc. | System and method for cooling the brain of a human subject |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2841863A1 (en) | 2011-07-25 | 2013-01-31 | Neurosave, Inc. | Non-invasive systems, devices, and methods for selective brain cooling |
US20150320592A1 (en) * | 2014-05-09 | 2015-11-12 | Scion Neurostim, Llc | Devices, Systems and Methods for Delivering Thermal Stimulation |
BR102015002008A2 (en) * | 2015-01-28 | 2016-08-23 | Bernardo Lembo Conde De Paiva | catheter |
US10788244B2 (en) * | 2016-02-01 | 2020-09-29 | Medtronic Cryocath Lp | Recovery system for N20 |
CN108030584A (en) * | 2017-12-24 | 2018-05-15 | 玉林市玉州区万通华信科技服务部 | A kind of nasa surgery cold compress device |
KR20210021737A (en) * | 2019-08-19 | 2021-03-02 | 아주대학교산학협력단 | Selective brain-cooling device for controlling cooling time without extracorporeal system |
CN111685927B (en) * | 2020-06-29 | 2022-03-15 | 北京中关村水木医疗科技有限公司 | Temperature control system and method of operating the same |
CN112741724A (en) * | 2021-01-07 | 2021-05-04 | 张晓平 | Portable nasal cavity sub-low temperature treatment device |
US20230010829A1 (en) * | 2021-07-08 | 2023-01-12 | Vikram Singh Bhinder | Patient targeted temperature management device and method |
CN114027964A (en) * | 2021-11-05 | 2022-02-11 | 首都医科大学附属北京天坛医院 | Flexible cryogenic spray tube for spray cryotherapy in airways and method of use thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006000006A2 (en) | 2004-06-23 | 2006-01-05 | Emcools-Emergency Medical Cooling Systems Ag | Device for cooling a patient and device for giving off cold to said patient |
US20080000532A1 (en) * | 2006-06-30 | 2008-01-03 | Matthew Lincoln Wagner | Low release rate cylinder package |
WO2008063179A1 (en) | 2006-11-22 | 2008-05-29 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
WO2008094505A1 (en) | 2007-01-26 | 2008-08-07 | William Cook Europe Aps | Apparatus and method for cooling the brain using a gas |
WO2011115964A1 (en) * | 2010-03-15 | 2011-09-22 | Muffin Incorporated | Apparatuses for cerebral cooling |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5755756A (en) * | 1995-09-15 | 1998-05-26 | Freedman, Jr.; Robert J. | Hypothermia-inducing resuscitation unit |
US6217552B1 (en) * | 1999-03-01 | 2001-04-17 | Coaxia, Inc. | Medical device for selective intrathecal spinal cooling in aortic surgery and spinal trauma |
US7824436B2 (en) * | 2005-05-13 | 2010-11-02 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
US20090259173A1 (en) * | 2006-06-23 | 2009-10-15 | Paul Wang | Cold Gas Spray For Stopping Nosebleeds |
US20090192505A1 (en) * | 2007-12-05 | 2009-07-30 | Reset Medical, Inc. | Method for cryospray ablation |
US20090234325A1 (en) * | 2008-03-17 | 2009-09-17 | Allan Rozenberg | Methods and devices for non-invasive cerebral and systemic cooling |
US8157767B2 (en) * | 2009-06-19 | 2012-04-17 | Benechill, Inc. | Devices for cooling the nasal cavity |
CA2841863A1 (en) * | 2011-07-25 | 2013-01-31 | Neurosave, Inc. | Non-invasive systems, devices, and methods for selective brain cooling |
-
2011
- 2011-12-02 EP EP11191745.6A patent/EP2599465B1/en not_active Not-in-force
-
2012
- 2012-08-14 BR BR112014013139A patent/BR112014013139A2/en not_active Application Discontinuation
- 2012-08-14 US US14/360,823 patent/US9622908B2/en not_active Expired - Fee Related
- 2012-08-14 CA CA2855859A patent/CA2855859A1/en not_active Abandoned
- 2012-08-14 WO PCT/EP2012/065843 patent/WO2013079227A1/en active Application Filing
- 2012-08-14 AU AU2012344233A patent/AU2012344233A1/en not_active Abandoned
- 2012-08-14 EP EP12748677.7A patent/EP2785293A1/en not_active Withdrawn
- 2012-08-14 CN CN201280059586.8A patent/CN103987346B/en not_active Expired - Fee Related
-
2014
- 2014-05-20 IL IL232722A patent/IL232722A0/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006000006A2 (en) | 2004-06-23 | 2006-01-05 | Emcools-Emergency Medical Cooling Systems Ag | Device for cooling a patient and device for giving off cold to said patient |
US20080000532A1 (en) * | 2006-06-30 | 2008-01-03 | Matthew Lincoln Wagner | Low release rate cylinder package |
WO2008063179A1 (en) | 2006-11-22 | 2008-05-29 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
WO2008094505A1 (en) | 2007-01-26 | 2008-08-07 | William Cook Europe Aps | Apparatus and method for cooling the brain using a gas |
WO2011115964A1 (en) * | 2010-03-15 | 2011-09-22 | Muffin Incorporated | Apparatuses for cerebral cooling |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018046128A1 (en) | 2016-09-09 | 2018-03-15 | Fabian Temme | Transportable device, system and method for providing a cooled, oxygen-containing gas flow |
US11395900B2 (en) | 2016-09-09 | 2022-07-26 | Fabian Temme | Transportable device, system and method for providing a cooled, oxygen-containing gas flow |
WO2019072423A1 (en) * | 2017-10-11 | 2019-04-18 | Quickcool Ab | System for hypothermia treatment of a patient |
US11737912B2 (en) | 2018-01-08 | 2023-08-29 | Vivonics, Inc. | System and method for cooling the brain of a human subject |
Also Published As
Publication number | Publication date |
---|---|
CN103987346A (en) | 2014-08-13 |
EP2599465B1 (en) | 2015-08-19 |
CN103987346B (en) | 2017-05-31 |
IL232722A0 (en) | 2014-07-31 |
BR112014013139A2 (en) | 2017-06-13 |
CA2855859A1 (en) | 2013-06-06 |
US20140330197A1 (en) | 2014-11-06 |
AU2012344233A1 (en) | 2014-06-26 |
EP2785293A1 (en) | 2014-10-08 |
EP2599465A1 (en) | 2013-06-05 |
US9622908B2 (en) | 2017-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9622908B2 (en) | Device and method for cooling a patient | |
CA2561589C (en) | Brain cooling apparatus and fluid injection apparatus used therefor | |
EP1888156B1 (en) | Devices for non-invasive cerebral and systemic cooling | |
EP2547389B1 (en) | Apparatuses for cerebral cooling | |
AU2016203347B2 (en) | Method And Device For Non-Invasive Anatomical And Systemic Cooling And Neuroprotection | |
US20180153737A1 (en) | Method and device for non-invasive anatomical and systemic cooling and neuroprotection | |
WO2010148372A1 (en) | Devices for cooling the nasal cavity | |
EP3043850B1 (en) | Insulated endotracheal devices and systems for transpulmonary thermal transfer | |
WO2008063179A1 (en) | Methods and devices for non-invasive cerebral and systemic cooling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12748677 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2855859 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 232722 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14360823 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2012344233 Country of ref document: AU Date of ref document: 20120814 Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2012748677 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012748677 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014013139 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112014013139 Country of ref document: BR Kind code of ref document: A2 Effective date: 20140530 |